Brought to you by:
SVS billing and coding workshop to take place Dec. 5 and 6
While a surgeon’s expertise is key to patient outcomes, coding and documenting the procedures are key to the surgeon’s payment and reimbursement. And, when it comes to billing and coding, a twist of an adage applies: What you don’t know…
SVS membership, CME-MOC deadlines fall in September
The third deadline of 2021 to apply for Society for Vascular Surgery (SVS) membership is Sept. 1. Be a part of the premiere organization representing vascular surgeons and allied health professions, and reap the substantial benefits SVS offers. These include…
VAM discussion on latest paclitaxel meta-analysis yields mix of caution, skepticism
A Vascular Annual Meeting (VAM) sponsored session on paclitaxel safety drew a mix of skeptical and cautious responses to the latest meta-analysis from interventional radiologist Konstantinos Katsanos, MD, that reported a heightened risk of major amputation after use of paclitaxel-coated balloons…
Amputation rates higher for people with PAD who are poor or Black
Poverty and Black race were associated with higher rates of lower-leg amputation among people with peripheral arterial disease (PAD) who live in metropolitan areas, according to new research published today in a special issue of the Journal of the American Heart Association (JAHA), an open…
Registration for UCLA-SVS vascular review course open
The Sixth Annual University of California Los Angeles (UCLA)-Society for Vascular Surgery (SVS) Symposium returns as a live course for 2021 from Oct. 1 to 3 at the Beverly Hilton in Beverly Hills, California. The October dates are a change…
First patient enrolled in AAA-SHAPE Netherlands study
Shape Memory Medical has announced the initiation of AAA-SHAPE Netherlands, the company’s prospective, multicenter early feasibility study of the Impede-FX RapidFill device when used for abdominal aortic aneurysm (AAA) sac management during elective endovascular aneurysm repair (EVAR). The Dutch study’s first procedure…
Vascular Quality Initiative launches ‘My PAD’ pilot
The Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) has created “My PAD,” a pilot program for collecting patient-reported outcomes (PROs) from patients undergoing endovascular treatment for peripheral arterial disease (PAD). Traditional outcomes such as patency and reintervention may…
SVS publishes diversity, equity and inclusion supplement—exploring route forward
On the heels of a worldwide pandemic that has helped expose deep disparities in healthcare, the Society for Vascular Surgery (SVS) published a response—and a promise—in the form of the 2021 diversity supplement, summarizing what Society members have learned and…
FDA approves expanded PAD indication for rivaroxaban plus aspirin
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Food and Drug Administration (FDA) has approved an expanded peripheral arterial disease (PAD) indication for the Xarelto (rivaroxaban) vascular dose (2.5mg twice daily plus aspirin 100mg once daily) to…
Caring for the veteran, training the surgeon: The role of the VA in vascular surgery training
In May 1945, President Harry Truman appointed Gen. Omar Bradley to lead what is now the United States Department of Veteran Affairs, with Paul Howley, MD, as chief medical director and orthopedic surgeon Paul Magnuson, MD, as his aide.1,2 Colloquially,…